CHICAGO—Clinicians giving potent combinations of antiretroviral drugs to patients with HIV to suppress the virus are finding just how much the effectiveness of such regimens depends on strict adherence.
Although there are many potential reasons—such as individual differences in drug absorption or metabolism—for the failure of highly active antiretroviral therapy (HAART) to keep a patient's HIV in check, experts believe the chief reason is poor adherence to treatment regimens, which can promote the emergence of drug-resistant strains. New findings presented at the 6th Conference on Retroviruses and Opportunistic Infections last month in Chicago underscored the importance of strict adherence in maintaining "virologic success"—sustained suppression of HIV—and examined factors associated with poor adherence.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 29
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Care at the Close of Life EDUCATION GUIDES
Overcoming the False Dichotomy of Curative vs Palliative Care for Late-Stage HIV/AIDS
All results at
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.